Healthcare & Biotech
Isabl
Cancer tests based on whole genome and transcriptome data.
Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations…
- Diagnostics
- Biotech
- Website
- isabl.io
- Headquarters
- New York City, NY, USA
- Team size
- 2-10 people
- Founded
- 2020
- Demo
- 45 min demo
Similar companies
Yemaachi BiotechnologyDiversifying precision cancer diagnostics and treatments
Signatur BiosciencesSimple tests for complex diseases.
Cofactor GenomicsCofactor closes the precision medicine gap with predictive diagnostics
NumenEngineering a future without cancer deaths.
Probably GeneticPatient Intelligence Platform for Genetic Disease
Clear GeneOur tests help eradicate cancer by telling doctors whether they got…
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
Adventris PharmaceuticalsAdventris makes cancer vaccines